References
- BottoLDMooreCAKhouryMJEricksonJDNeural-tube defectsN Engl J Med1999341201509151910559453
- CheschierNfor ACOG Committee on Practice Bulletins-ObstetricsACOG practice bulletin. Neural tube defects Number 44. Jul 2003 (Replaces committee opinion number 252 Mar 2001)Int J Gynaecol Obstet200383112313314626221
- National Heart Lung, and Blood InstituteTypes of congenital heart defects [webpage on the Internet]Bethesda, MDUnited States Department of Health and Human Services2011 Available from: http://www.nhlbi.nih.gov/health/health-topics/topics/chd/types.htmlAccessed June 12, 2012
- De-RegilLMFernández-GaxiolaACDowswellTPena-RosasJPEffects and safety of periconceptional folate supplementation for preventing birth defectsCochrane Database Syst Rev201010CD00795020927767
- European Surveillance of Congenital Anomalies (EUROCAT)Special Report: Prevention of Neural Tube Defects by Periconceptional Folic Acid Supplementation in Europe. Part IIa–Country Specific Chapters (Austria to Ireland)Newtonabbey, IrelandEuropean Surveillance of Congenital Anomalies2009 Available from: http://www.eurocat-network.eu/content/Special-Report-NTD-3rdEd-Part-IIA.pdfAccessed October 6, 2010
- European Surveillance of Congenital Anomalies (EUROCAT)Special Report: Prevention of Neural Tube Defects by Periconceptional Folic Acid Supplementation in Europe. Part IIb–Country Specific Chapters (Italy to UK)Newtonabbey, IrelandEuropean Surveillance of Congenital Anomalies2009 Available from: http://www.eurocat-network.eu/content/Special-Report-NTD-3rdEd-Part-IIB.pdfAccessed October 6, 2010
- US Preventive Services Task ForceFolic acid for the prevention of neural tube defects: US Preventive Services Task Force recommendation statementAnn Intern Med2009150962663119414842
- Centers for Disease Control and Prevention (CDC)Spina bifida and anencephaly before and after folic acid mandate – United States, 1995–1996 and 1999–2000MMWR Morb Mortal Wkly Rep2004531736236515129193
- BusbyAAbramskyLDolkHArmstrongBfor Eurocat Folic Acid Working GroupPreventing neural tube defects in Europe: population based studyBMJ2005330749157457515760997
- BaykanZOztürkAPoyrazoğluSGünIAwareness, knowledge, and use of folic acid among women: a study from TurkeyArch Gynecol Obstet2011283612591253
- OddyWHMillerMPayneJMSernaPBowerCIAwareness and consumption of folate-fortified foods by women of childbearing age in Western AustraliaPublic Health Nutr2007101098999517683648
- PötzschSHoyer-SchuschkeJSeeligMSteinbickerVKnowledge among young people about folic acid and its importance during pregnancy: a survey in the Federal State of Saxony-Anhalt (Germany)J Appl Genet200647218719016682762
- SayedARNixonJBourneDEFolic acid awareness among women of reproductive age in Cape TownS Afr Med J20069611216440103
- KondoAKamihiraOShimosukaYOkaiIGotohMOzawaHAwareness of the role of folic acid, dietary folate intake and plasma folate concentration in JapanJ Obstet Gynaecol Res200531217217715771645
- FrenchMRBarrSILevy-MilneRFolate intakes and awareness of folate to prevent neural tube defects: a survey of women living in Vancouver, CanadaJ Am Diet Assoc2003103218118512589323
- RingelSLahatEElizovTAwareness of folic acid for neural tube defect prevention among Israeli womenTeratology1999601293210413336
- CastillaEEDutraMGFolate awareness among South American womenLancet199734990537359078232
- von StenglinABuchwaldSLynenRWomen’s awareness and use of folate supplements prior to and during pregnancy: a global perspectiveEur J Contracept Reprod Health Care201015s1111112
- Green-RaleighKCarterHMulinareJPrueCPetriniJTrends in folic acid awareness and behavior in the United States: the Gallup Organization for the March of Dimes Foundation surveys, 1995–2005Matern Child Health J200610Suppl 5S177S18216823638
- Centers for Disease Control and Prevention (CDC)Use of supplements containing folic acid among women of childbearing age – United States, 2007MMWR Morb Mortal Wkly Rep20085715818185493
- von StenglinABuchwaldSLynenRPhysicians’ knowledge and prescribing practices of folic acid supplementation: a global perspectiveEur J Contracept Reprod Health Care201015s1112113
- RayJGSinghGBurrowsRFEvidence for suboptimal use of periconceptional folic acid supplements globallyBJOG2004111539940815104602
- FinerLBHenshawSKDisparities in rates of unintended pregnancy in the United States, 1994 and 2001Perspect Sex Reprod Health2006382909616772190
- KnudsenVKOrozova-BekkevoldIRasmussenLBMikkelsenTBMichaelsenKFOlsenSFLow compliance with recommendations on folic acid use in relation to pregnancy: is there a need for fortification?Public Health Nutr20047784385015482608
- PorettiAAnheierTZimmermannRBoltshauserEfor Swiss Pediatric Surveillance Unit (SPSU)Neural tube defects in Switzerland from 2001 to 2007: are periconceptual folic acid recommendations being followed?Swiss Med Wkly200813841–4260861318941947
- DalyLEKirkePNMolloyAWeirDGScottJMFolate levels and neural tube defects. Implications for preventionJAMA199527421169817027474275
- European Surveillance of Congenital Anomalies (EUROCAT)Special Report: Prevention of Neural Tube Defects by Periconceptional Folic Acid Supplementation in EuropeNewtonabbey, IrelandEuropean Surveillance of Congenital Anomalies2009 Available from: http://www.eurocat-network.eu/content/Special-Report-NTD-3rdEd-Part-I.pdfAccessed October 6, 2010
- Centers for Disease Control and Prevention (CDC)Trends in wheat-flour fortification with folic acid and iron – worldwide, 2004 and 2007MMWR Morb Mortal Wkly Rep200857181018185494
- EichholzerMTönzOZimmermannRFolic acid: a public-health challengeLancet200636795191352136116631914
- United States Food and Drug AdministrationSummary minutes advisory committee for reproductive health drugs meeting December 15, 2003 [webpage on the Internet]Bethesda, MDUnited States Food and Drug Administration2003 Available from: http://www.fda.gov/ohrms/dockets/ac/03/minutes/4002M1_Final.htmAccessed December 20, 2012
- LassiZSBhuttaZAClinical utility of folate-containing oral contraceptivesInt J Womens Health2012418519022570577
- DiefenbachKTrummerDEbertFEthinylestradiol/drospirenone/levomefolate calcium versus ethinylestradiol/drospirenone + folic acid: folate status during 24 weeks of treatment and over 20 weeks following treatment cessationInt J Womens Health2013514916323610531